Assessment of T Regulatory Cells and Expanded Profiling of Autoantibodies May Offer Novel Biomarkers for the Clinical Management of Systemic Sclerosis and Undifferentiated Connective Tissue Disease
Figure 3
Correlation of T reg cell levels and disease duration in all patients (a), patients with UCTD (b), patients with SSc, limited (c), or diffuse (d) disease.
